Lisa A. Santry

628 total citations
23 papers, 472 citations indexed

About

Lisa A. Santry is a scholar working on Genetics, Infectious Diseases and Epidemiology. According to data from OpenAlex, Lisa A. Santry has authored 23 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 7 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Lisa A. Santry's work include Virus-based gene therapy research (15 papers), Viral gastroenteritis research and epidemiology (6 papers) and CAR-T cell therapy research (5 papers). Lisa A. Santry is often cited by papers focused on Virus-based gene therapy research (15 papers), Viral gastroenteritis research and epidemiology (6 papers) and CAR-T cell therapy research (5 papers). Lisa A. Santry collaborates with scholars based in Canada, United States and Germany. Lisa A. Santry's co-authors include Sarah K. Wootton, Jim Petrik, Byram W. Bridle, Jacob P. van Vloten, Pierre Major, Kathy Matuszewska, Geoffrey A. Wood, Joelle C. Ingrao, Laura P. van Lieshout and Jack Lawler and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Frontiers in Microbiology.

In The Last Decade

Lisa A. Santry

23 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa A. Santry Canada 14 191 157 140 90 86 23 472
Thomas Speiseder Germany 10 391 2.0× 232 1.5× 105 0.8× 91 1.0× 96 1.1× 18 548
Janet Lei-Rossmann United Kingdom 12 143 0.7× 233 1.5× 231 1.6× 67 0.7× 82 1.0× 19 396
Cuizhu Zhang China 14 210 1.1× 143 0.9× 107 0.8× 223 2.5× 140 1.6× 25 493
Yanal Murad Canada 14 226 1.2× 108 0.7× 166 1.2× 97 1.1× 209 2.4× 26 583
Anagha P. Phadke United States 10 223 1.2× 207 1.3× 152 1.1× 118 1.3× 124 1.4× 14 527
Sanggu Kim United States 11 272 1.4× 171 1.1× 69 0.5× 80 0.9× 225 2.6× 29 581
Matthew C. Jarvis United States 15 259 1.4× 120 0.8× 135 1.0× 66 0.7× 82 1.0× 19 585
Shyambabu Chaurasiya United States 18 203 1.1× 414 2.6× 406 2.9× 51 0.6× 128 1.5× 33 636
Jordan M. Meyers United States 8 126 0.7× 61 0.4× 133 0.9× 243 2.7× 86 1.0× 9 422

Countries citing papers authored by Lisa A. Santry

Since Specialization
Citations

This map shows the geographic impact of Lisa A. Santry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa A. Santry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa A. Santry more than expected).

Fields of papers citing papers by Lisa A. Santry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa A. Santry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa A. Santry. The network helps show where Lisa A. Santry may publish in the future.

Co-authorship network of co-authors of Lisa A. Santry

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa A. Santry. A scholar is included among the top collaborators of Lisa A. Santry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa A. Santry. Lisa A. Santry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santry, Lisa A., Jacob P. van Vloten, Jim Petrik, et al.. (2024). Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer. Frontiers in Microbiology. 15. 1325558–1325558. 6 indexed citations
2.
Pei, Yanlong, Laura P. van Lieshout, Lisa A. Santry, et al.. (2023). Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis. Gene Therapy. 32(1). 38–49. 3 indexed citations
3.
Vloten, Jacob P. van, Lisa A. Santry, Kathy Matuszewska, et al.. (2023). Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer. Molecular Therapy — Oncolytics. 31. 100748–100748. 2 indexed citations
4.
Stegelmeier, Ashley A., Lisa A. Santry, Kathy Matuszewska, et al.. (2022). AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma. Biomedicines. 10(2). 362–362. 6 indexed citations
5.
6.
Vloten, Jacob P. van, Joelle C. Ingrao, Lisa A. Santry, et al.. (2021). Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy. Molecular Therapy — Methods & Clinical Development. 23. 434–447. 9 indexed citations
7.
8.
Vloten, Jacob P. van, Lisa A. Santry, Joelle C. Ingrao, et al.. (2021). Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models. Molecular Therapy — Oncolytics. 20. 306–324. 20 indexed citations
9.
Lieshout, Laura P. van, Lisa A. Santry, Sylvia P. Thomas, et al.. (2020). AAV Vectored Immunoprophylaxis for Filovirus Infections. Tropical Medicine and Infectious Disease. 5(4). 169–169. 13 indexed citations
10.
Santry, Lisa A., Jacob P. van Vloten, Kathy Matuszewska, et al.. (2020). Tumour vasculature: Friend or foe of oncolytic viruses?. Cytokine & Growth Factor Reviews. 56. 69–82. 22 indexed citations
11.
12.
Vloten, Jacob P. van, Lisa A. Santry, Khalil Karimi, et al.. (2019). Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies. Molecular Therapy — Methods & Clinical Development. 13. 154–166. 14 indexed citations
13.
Matuszewska, Kathy, Lisa A. Santry, Jacob P. van Vloten, et al.. (2018). Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer. Clinical Cancer Research. 25(5). 1624–1638. 60 indexed citations
14.
Vloten, Jacob P. van, Lisa A. Santry, Adrian Pelin, et al.. (2018). Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy. Molecular Therapy — Methods & Clinical Development. 10. 245–256. 39 indexed citations
15.
Santry, Lisa A., et al.. (2017). AAV vector distribution in the mouse respiratory tract following four different methods of administration. BMC Biotechnology. 17(1). 43–43. 40 indexed citations
16.
Santry, Lisa A., Leonardo Susta, Geoffrey A. Wood, et al.. (2017). Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer. Molecular Therapy — Methods & Clinical Development. 9. 181–191. 31 indexed citations
17.
Walsh, Scott R., et al.. (2016). Truncation of the enzootic nasal tumor virus envelope protein cytoplasmic tail increases Env-mediated fusion and infectivity. Journal of General Virology. 98(1). 108–120. 5 indexed citations
18.
Santry, Lisa A., et al.. (2014). Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression. PLoS ONE. 9(4). e94595–e94595. 52 indexed citations
19.
Santry, Lisa A., et al.. (2013). Genetic characterization of small ruminant lentiviruses circulating in naturally infected sheep and goats in Ontario, Canada. Virus Research. 175(1). 30–44. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Speiseder Breakdown of academic impact, for papers by Janet Lei-Rossmann Breakdown of academic impact, for papers by Cuizhu Zhang Breakdown of academic impact, for papers by Yanal Murad Breakdown of academic impact, for papers by Anagha P. Phadke Breakdown of academic impact, for papers by Sanggu Kim Breakdown of academic impact, for papers by Matthew C. Jarvis Breakdown of academic impact, for papers by Shyambabu Chaurasiya Breakdown of academic impact, for papers by Jordan M. Meyers
Rankless by CCL
2026